CPT® Code 0709T

Add-On Code

Intradermal cancer immunotherapy is a treatment approach that leverages the body's immune system to combat cancer. Unlike traditional chemotherapy, which directly targets and kills cancer cells, immunotherapy aims to enhance and activate the immune response to identify and destroy cancerous cells. This method utilizes the body's natural defenses, making it a promising avenue for cancer treatment. However, it is important to note that immunotherapy can lead to significant side effects in some patients, including cytokine release syndrome, vascular leak syndrome, and autoimmune reactions, which can be serious or even fatal. The administration of immunotherapy through injections allows for a more localized treatment strategy, targeting tumors more effectively while reducing the systemic toxicity often associated with broader treatment methods. Intradermal injections, in particular, are advantageous due to the higher concentration of dendritic cells in the dermis. These cells play a crucial role in capturing antigens and stimulating T-cells, thereby enhancing the immune response against tumors. For billing purposes, the CPT® code 0708T is used to report the preparation and initial intradermal injection of an immunotherapy treatment, while CPT® code 0709T is designated for each additional injection administered in the course of treatment.